Skip to main content
Clinical Trials/NCT03295630
NCT03295630CompletedNot Applicable

Criterion Validity of the Actigraph GT3X Accelerometer in Determination of Body Position and Walking in Hospital Ward Patients Recovering From Critical Illness

Hull University Teaching Hospitals NHS Trust1 site in 1 country20 target enrollmentStarted: September 19, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Ability of an Accelerometer to Identify Step Count

Study Overview

Brief Summary

This study will determine whether an Actigraph GT3X accelerometer can identify body position and quantify step count in a ward based population recovering from critical illness.

Detailed Description

Ward based patients recovering from critical illness who satisfy the inclusion criteria will have an Actigraph GT3X accelerometer positioned on the thigh and ankle of the non dominant leg. These will be used as an objective method of identifying adoption of lying, sitting and standing postures and quantification of step count. Both placement sites will be investigated in isolation. A further analysis will be undertaken to determine whether combining data from both placement sites (ankle and thigh) is superior in identification of lying, sitting and standing postures compared to an isolated single site. Accelerometer data will be compared against direct observation as the criterion measure.

Patients will undertake a semi-structured movement protocol consisting of typical activities undertaken by this population. These include lying in bed, transferring over the side of the bed, sit to stand postural transfers (and the reverse), sitting in a chair and walking. Observation periods will not exceed 3 hours. During this time all aspects of the movement protocol will be completed.

The data from this study will be analysed to determine the validity of the Actigraph GT3X in identification of body position and quantification of step count using the placement sites described above.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •1 18 years of age or above.
  • •Ventilated in excess of 48 hours during admission in the Intensive Care Unit (ICU).
  • •Currently resident on a hospital ward (secondary care) following step down from ICU
  • •Able to undertake all postural transfers independently or with minimal assistance (one person only).
  • •Able to mobilise short distances, either independently or with assistance from a walking aid or one person.
  • •Willing to permit application of two Actigraph GT3X accelerometers Each device weighs 27g with dimensions of 3.8cm x 3.7cm x 1.8cm.
  • •Willing to consent to a period of direct observation for a length of time not exceeding three hours.

Exclusion Criteria

  • •Unable to provide informed written consent themselves
  • •Unwilling to consent to a period of observation not exceeding three hours.
  • •Unable to make an informed decision about participation or demonstrating an inability to interpret information or follow study instructions
  • •Significant neurological or coordination impairment
  • •Unable to speak or understand English.
  • •Clostridium Difficile/ similar infection or unmanaged urinary incontinence.
  • •Evidence/ diagnosis of peripheral vascular disease.
  • •Lower limb amputation
  • •Polytrauma which prevents the adoption or normal lying, sitting or standing postures, or placement of the accelerometers

Arms & Interventions

Actigraph GT3X accelerometer

Other

Ward based patients recovering from critical illness will wear two accelerometers placed on the thigh and ankle of the non-dominant leg

Intervention: Accelerometer (Device)

Outcomes

Primary Outcomes

Ability of an Accelerometer to Identify Step Count

Time Frame: Participants wore the accelerometers for a maximum of 3 hours, undertaking a semi-structured movement protocol

Agreement between direct observation and the activity monitors (ankle and thigh placements in isolation) in determination of step count. The mean difference (95% Limits of Agreement) between observed step count and accelerometer quantified step count for the same walk were calculated. Negative values reflected an underestimation of observed step count by the accelerometer and positive values reflected an overestimation of step count.

Secondary Outcomes

  • Comfort of Accelerometers(Accelerometers were worn for a period not exceeding 3 hours)

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials